# Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ib-dose-expansion-and-translational-analyses-of-olaparib-in-combination/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shannon N. Westin,Marilyne Labrie,Jennifer K. Litton,Aurora Blucher,Yong Fang,Christopher P. Vellano,Joseph R. Marszalek,Ningping Feng,Xiaoyan Ma,Allison Creason,Bryan Fellman,Ying Yuan,Sanghoon Lee,Tae‐Beom Kim,Jinsong Liu,Anca Chelariu-Raicu,Tsun Hsuan Chen,Nashwa Kabil,Pamela T. Soliman,Michael Frumovitz,Katheleen M. Schmeler,Amir A. Jazaeri,Karen H. Lu,Rashmi K. Murthy,Larissa A. Meyer,Charlotte C. Sun,Anil K. Sood,Robert L. Coleman,Gordon B. Mills |
| Citations | 76 |
| DOI | 10.1158/1078-0432.ccr-21-1656 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://aacrjournals.org/clincancerres/article-pdf/27/23/6354/3015482/6354.pdf |
| OpenAlex ID | https://openalex.org/W3199661675 |
| PMID | 34518313 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Xiaoyan Ma](https://scholariq.org/researchers/xiaoyan-ma/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.